Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 215

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 215
---
arrants will expire worthless. APx may not have sufficient funds to satisfy indemnification claims of the Initial Shareholders. APx has agreed to indemnify the Initial Shareholders to the fullest extent permitted by law. However, the Initial Shareholders have agreed to waive any right, title, interest or claim of any kind in or to any monies in the Trust Account and to not seek recourse against the Trust Account for any reason whatsoever. Accordingly, any indemnification provided will be able to be satisfied by APx only if (i) APx has sufficient funds outside of the Trust Account or (ii) APx consummates the Business Combination. APx’s obligation to indemnify its officers and directors may discourage shareholders from bringing a lawsuit against the Initial Shareholders for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against the Initial Shareholders, even though such an action, if successful, might otherwise benefit APx and its shareholders. Furthermore, a shareholder’s investment may be adversely affected to the extent APx pays the costs of settlement and damage awards against the Initial Shareholders pursuant to these indemnification provisions. APx’s Initial Shareholders, executive officers and directors have potential conflicts of interest in recommending that shareholders vote in favor of approval of the Business Combination Proposal and approval of the other proposals described in this proxy statement / prospectus. In considering the recommendation of the APx Board to vote in favor of the Business Combination, shareholders should be aware that, aside from their interests as shareholders, our Sponsor and our directors and officers and the Company’s current shareholders have interests in the Business Combination that are different from, or in addition to, those of our other shareholders generally. Our directors were aware of and considered these interests, among other matters, in evaluating the Business Combination, and in recommending to our shareholders that they approve the Business Combination. Shareholders should take these interests into account in deciding whether to approve the Business Combination. These interests include, among other things: •the Initial Shareholders will lose their entire investment in APx if APx does not complete an initial business combination by the Extended Date; •the beneficial ownership of the Initial Shareholders of an aggregate of 4,312,500 SPAC Class A Ordinary Shares, comprised of 3,342,188 SPAC Class A Ordinary Shares held by the Sponsor (which shares were purchased in connection with the Sponsor Alliance) and 970,312 SPAC Class A Ordinary Shares held by the Initial Sponsor which were purchased in connection with the IPO